This information sheet discusses drug-associated transmission of HIV in the United States and prevention strategies for injection drug users (IDUs). It reviews the risks associated with sharing needles, having sex with an IDU, and trading sex for drugs or engaging in other risky sexual behaviors. Injection drug use has directly and indirectly accounted for 36% of AIDS cases in the US. Of the 42,156 new cases of AIDS reported in 2000, 11,635 (28%) were IDU-associated.
This report discusses a client-centered approach to treating latent tuberculosis infection (LTBI) in substance abusers at an outpatient treatment facility. The report describes needs assessment at a specific clinic, including the client profile, initial medical screening, existing TB follow-up procedures, problems with the existing follow-up procedures, and the strategy for implementation. The implementation plan, its objectives, revised procedures and advantages of the revised procedures are presented. The report includes the results of this new treatment approach and follow-up procedures.
This report discusses substitution maintenance to manage opioid dependence and prevent HIV among injecting drug users (IDUs). The report explains the epidemiology, nature, and cost to society of opioid dependence as well as a definition and rationale for substitution therapy. The report lists the following drugs used in substitution therapy: methadone, buprenorphine, levo alpha acetyl methadol (LAAM), dihydrocodeine, and diacetylmorphine and explains how they are used.
This information sheet presents basic information for injecting drug users (IDUs) on disinfection, especially bleach disinfection, of drug injection equipment to reduce the risk of getting or transmitting HIV or HCV.
This Teaching Guide can help health professionals learn ways to discuss alcohol use with patients who have hepatitis C. There is an enclosed motivational counseling card, which is one of many tools that can be used to help patients with hepatitis C reduce or eliminate alcohol consumption.
This information sheet describes Modelo de Intervencion Psicomedica (MIP), an HIV/AIDS psycho-medical intervention for use with injection drug users aged 18 years and older. The program offers seven one-on-one counseling sessions over 3-6 months and is conducted by a team of trained and qualified staff. The information sheet lists the objectives of the program, its core elements, the target audience, materials, and training, and provides contact information for technical assistance or training.
There are more tools to effectively prevent HIV than ever before. Since no single strategy provides complete protection or is right for all individuals, a combination of methods is needed to help reduce HIV transmission. CDC and its partners are currently pursuing a High-Impact Prevention approach to reducing the continued toll of HIV. This approach seeks to use the best mix of proven, cost-effective, and scalable interventions for high-risk populations and areas of the nation (see "Future of HIV Prevention" fact sheet for information).